Article Text

Download PDFPDF
CASE REPORT
An unusual manifestation of olfactory neuroblastoma
  1. Zona Batacchi1,
  2. Nicole K Andeen2,
  3. Subbulaxmi Trikudanathan1
  1. 1Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA
  2. 2Department of Pathology, University of Washington, Seattle, Washington, USA
  1. Correspondence to Dr Subbulaxmi Trikudanathan, tsubbu{at}uw.edu

Summary

A 62-year-old woman presented with an 11-month history of worsening nasal symptoms of rhinorrhoea, anosmia, nasal congestion and intermittent epistaxis. MRI revealed a large mass in the upper nasal vault. Biopsy of the mass revealed an olfactory neuroblastoma. While waiting resection, she acutely developed severe proximal muscle weakness, lethargy and lower extremity oedema. Blood glucose was elevated, and hypokalaemic metabolic alkalosis was noted. Elevated serum cortisol level of 95.7 µg/dL (8.7–22.4 µg/dL) and markedly elevated 24-hour urinary cortisol level of 6962.3 µg/24 hours (4.0–50.0 µg/24 hours) with concurrent adrenocorticotropic hormone (ACTH) level of 171 pg/mL (6–58 pg/mL) were suggestive of an ACTH-dependent source of hypercortisolism. A subsequent positive high-dose dexamethasone suppression test was consistent with ectopic ACTH production. She underwent near-total resection of the right nasal mass followed by radiotherapy, resulting in complete resolution of signs and symptoms of cortisol excess.

  • endocrine system
  • malignant disease and immunosuppression
  • ear, nose and throat/otolaryngology
  • endocrine cancer

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors ZB and NKA drafted the manuscript and prepared the figures. All authors edited and revised the manuscript and approved the final version. ZB and ST conceived and designed the report.

  • Funding This study was funded by the National Institutes of Health (T32HL007028).

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.